{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:52Z","timestamp":1761513532830},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.2146\/ajhp140039","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T17:55:14Z","timestamp":1413395714000},"page":"1862-1869","source":"Crossref","is-referenced-by-count":8,"title":["Impact of a phenytoin loading dose program in the emergency department"],"prefix":"10.1093","volume":"71","author":[{"given":"Adam","family":"Brancaccio","sequence":"first","affiliation":[{"name":"University of Michigan Health System, Ann Arbor, and Adjunct Clinical Faculty, University of Michigan College of Pharmacy, Ann Arbor; at the time of writing, he was Postgraduate Year 1 Pharmacy Practice Resident, Department of Pharmacy, St. John Hospital and Medical Center (SJHMC), Detroit, MI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, and Clinical Specialist, Internal Medicine, Department of Pharmacy, SJHMC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"McNorton","sequence":"additional","affiliation":[{"name":"Critical Care;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"George","family":"Delgado","sequence":"additional","affiliation":[{"name":"Emergency Medicine\/Infectious Diseases, Department of Pharmacy, SJHMC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041211193510200_b1-0711862","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"key":"2019041211193510200_b2-0711862","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1378\/chest.126.2.582","article-title":"The management of status epilepticus","volume":"126","author":"Marik","year":"2004","journal-title":"Chest"},{"key":"2019041211193510200_b3-0711862","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0733-8619(05)70022-0","article-title":"Treatment of status epilepticus","volume":"19","author":"Smith","year":"2001","journal-title":"Neurol Clin"},{"key":"2019041211193510200_b4-0711862","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","article-title":"Recommendations of the Epilepsy Foundation of America\u2019s Working Group on Status Epilepticus","volume":"270","author":"Treatment of convulsive status epilepticus","year":"1993","journal-title":"JAMA"},{"key":"2019041211193510200_b5-0711862","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.annemergmed.2004.01.017","article-title":"Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures","volume":"43","year":"2004","journal-title":"Ann Emerg Med"},{"key":"2019041211193510200_b6-0711862","article-title":"Phenytoin","volume-title":"Applied clinical pharmacokinetics","author":"Bauer","year":"2008","edition":"2nd ed"},{"key":"2019041211193510200_b7-0711862","article-title":"Clinical pharmacokinetics and pharmacodynamics","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"Bauer","year":"2011","edition":"8th ed"},{"key":"2019041211193510200_b8-0711862","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007691-199802000-00012","article-title":"Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus","volume":"20","author":"Dasgupta","year":"1998","journal-title":"Ther Drug Monit"},{"key":"2019041211193510200_b9-0711862","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/clinchem\/37.1.98","article-title":"Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin, and sulfamethoxazole","volume":"37","author":"Dasgupta","year":"1991","journal-title":"Clin Chem"},{"key":"2019041211193510200_b10-0711862","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00007691-199602000-00016","article-title":"In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera","volume":"18","author":"Dasgupta","year":"1996","journal-title":"Ther Drug Monit"},{"key":"2019041211193510200_b11-0711862","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/j.1875-9114.1997.tb03723.x","article-title":"Phenytoin-oxacillin interactions in normal and uremic sera","volume":"17","author":"Dasgupta","year":"1997","journal-title":"Pharmacotherapy"},{"key":"2019041211193510200_b12-0711862","first-page":"24","article-title":"Binding parameters of phenytoin during monotherapy and polytherapy","volume":"30","author":"Posp\u00edsil","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"2019041211193510200_b13-0711862","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1592\/phco.28.11.1391","article-title":"Therapeutic drug monitoring of phenytoin in critically ill patients","volume":"28","author":"Von Winckelmann","year":"2008","journal-title":"Pharmacotherapy"},{"key":"2019041211193510200_b14-0711862","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/106002809502900503","article-title":"Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods","volume":"29","author":"Kerrick","year":"1995","journal-title":"Ann Pharmacother"},{"key":"2019041211193510200_b15-0711862","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1528-1157.2000.tb00144.x","article-title":"A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy","volume":"41","author":"Jannuzzi","year":"2000","journal-title":"Epilepsia"},{"key":"2019041211193510200_b16-0711862","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archneur.1974.00490410037002","article-title":"Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures","volume":"31","author":"Lund","year":"1974","journal-title":"Arch Neurol"},{"key":"2019041211193510200_b17-0711862","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007691-198901000-00007","article-title":"The impact of a therapeutic drug monitoring program for phenytoin","volume":"11","author":"Wing","year":"1989","journal-title":"Ther Drug Monit"},{"key":"2019041211193510200_b18-0711862","first-page":"219","article-title":"Efficacy of individualized phenytoin sodium loading doses administered by intravenous infusion","volume":"7","author":"Dela Cruz","year":"1988","journal-title":"Clin Pharm"},{"key":"2019041211193510200_b19-0711862","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198510010-00001","article-title":"Comparison of drug dosing methods","volume":"10","author":"Burton","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"2019041211193510200_b20-0711862","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1592\/phco.21.17.1407.34433","article-title":"Three Michaelis-Menten pharmacokinetic dosing methods compared with physician dosing of phenytoin in an outpatient neurology practice","volume":"21","author":"Spruill","year":"2001","journal-title":"Pharmacotherapy"},{"key":"2019041211193510200_b21-0711862","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2710.1990.tb00352.x","article-title":"Phenytoin dosage individualization\u2014five methods compared in the elderly","volume":"15","author":"Hudson","year":"1990","journal-title":"J Clin Pharm Ther"},{"key":"2019041211193510200_b22-0711862","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archneur.1985.04060050066010","article-title":"Phenytoin disposition in obesity. Determination of loading dose","volume":"42","author":"Abernethy","year":"1985","journal-title":"Arch Neurol"},{"key":"2019041211193510200_b23-0711862","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00134-003-2059-6","article-title":"Dosing of medications in morbidly obese patients in the intensive care unit setting","volume":"30","author":"Erstad","year":"2004","journal-title":"Intensive Care Med"},{"issue":"suppl 3","key":"2019041211193510200_b24-0711862","first-page":"120","article-title":"Obesity\u2014United States, 1999\u20132010","volume":"62","author":"May","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"2019041211193510200_b25-0711862","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008023","article-title":"When less is more: a case of phenytoin toxicity","volume":"2013","author":"Robertson","year":"2013","journal-title":"BMJ Case Rep"},{"key":"2019041211193510200_b26-0711862","first-page":"992","article-title":"Severe phenytoin intoxication in patients with hypoalbuminaemia","volume":"151","author":"Nicolai","year":"2007","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2019041211193510200_b27-0711862","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.ajkd.2004.09.016","article-title":"Phenytoin intoxication in critically ill patients","volume":"45","author":"De Schoenmakere","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2019041211193510200_b28-0711862","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/clinchem\/46.8.1132","article-title":"Evidence-based implementation of free phenytoin therapeutic drug monitoring","volume":"46","author":"Burt","year":"2000","journal-title":"Clin Chem"},{"key":"2019041211193510200_b29-0711862","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/ajhp\/55.16.1726","article-title":"ASHP statement on the pharmacist\u2019s role in clinical pharmacokinetic monitoring","volume":"55","year":"1998","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041211193510200_b30-0711862","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1345\/aph.18192","article-title":"Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service","volume":"34","author":"Dager","year":"2000","journal-title":"Ann Pharmacother"},{"key":"2019041211193510200_b31-0711862","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2146\/ajhp040555","article-title":"Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy","volume":"62","author":"Bond","year":"2005","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041211193510200_b32-0711862","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2146\/ajhp100242","article-title":"Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program","volume":"68","author":"Wellman","year":"2011","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041211193510200_b33-0711862","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1592\/phco.22.3.251.33547","article-title":"Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury","volume":"22","author":"Brophy","year":"2002","journal-title":"Pharmacotherapy"},{"key":"2019041211193510200_b34-0711862","first-page":"61","article-title":"Influence of clinical pharmacist consultations on the use of drug blood level tests","volume":"37","author":"Elenbaas","year":"1980","journal-title":"Am J Hosp Pharm"},{"key":"2019041211193510200_b35-0711862","first-page":"1500","article-title":"Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs","volume":"92","author":"Ratanajamit","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"2019041211193510200_b36-0711862","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2710.1999.00241.x","article-title":"Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa","volume":"24","author":"Valodia","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"2019041211193510200_b37-0711862","first-page":"873","article-title":"Benefits of a clinical pharmacokinetic service in optimising phenytoin use in the Western Cape","volume":"88","author":"Valodia","year":"1998","journal-title":"S Afr Med J"},{"key":"2019041211193510200_b38-0711862","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"2019041211193510200_b39-0711862","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1197\/j.aem.2004.10.005","article-title":"Who should be estimating a patient\u2019s weight in the emergency department?","volume":"12","author":"Corbo","year":"2005","journal-title":"Acad Emerg Med"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/21\/1862\/28373600\/ajhp1862.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T23:20:48Z","timestamp":1717456848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/21\/1862\/5111136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":39,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140039","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,11,1]]},"published":{"date-parts":[[2014,11,1]]}}}